Early Outcomes of Volar Capsulodesis for the Treatment of Scapholunate Ligament Injury


About this study

The purpose of this study is to:

  1. To provide a comprehensive review of Mayo Clinic’s experience with volar SLIL capsulodesis
  2. Investigate the relationships between patient risk factors and clinical variables with functional outcomes and patient satisfaction
  3. Determine rates of complication, revision surgeries and salvage for failure

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Ages 18 and older with a clinical diagnosis of SL injuries requiring surgical intervention at Mayo Clinic Rochester as determined by health records

Exclusion Criteria: 

  • Less than 18 years old


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Steven Moran, M.D.

Contact us for the latest status

Contact information:

Steven Moran M.D.



More information


Publications are currently not available

Mayo Clinic Footer